Cargando…
Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
Classic hairy cell leukemia (HCL) is a rare indolent B‑cell-lymphoproliferative disorder, first described as a distinct disease entity in 1958. After more than two decades without effective chemotherapeutic options and a dismal prognosis of less than 5 years, only the introduction of interferon‑α (I...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923076/ https://www.ncbi.nlm.nih.gov/pubmed/27429657 http://dx.doi.org/10.1007/s12254-016-0269-1 |